Search

everythinglearnresearchcommunity

for

Search:↓

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Dermoscopy quickly and accurately diagnosed a rare hair disorder in a 12-year-old girl.

A new therapy for a skin blistering condition has not been developed yet.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Type IV collagen chains vary in different parts of human skin, with specific patterns linked to melanocytes.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Infliximab may cause hair loss in Crohn's disease patients.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Keratin treatment reduces astrocyte reactivity and inflammation.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Hyper-keratinisation in Meibomian glands contributes to gland dysfunction.

The rash resolved after stopping ponatinib.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Amyloid deposits linked to a type of protein may cause a unique pattern of hair loss by disrupting hair growth cycles.

Some people with chronic hair loss may have thyroid autoimmunity.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.